최소 단어 이상 선택하여야 합니다.
최대 10 단어까지만 선택 가능합니다.
다음과 같은 기능을 한번의 로그인으로 사용 할 수 있습니다.
NTIS 바로가기Clinical pharmacology and therapeutics, v.93 no.5, 2013년, pp.399 - 401
Ogishima, S , Mizuno, S , Kikuchi, M , Miyashita, A , Kuwano, R , Tanaka, H , Nakaya, J
Alzheimers disease (AD) is a complex neurodegenerative condition, and its drug therapy is challenging. To inform AD drug discovery, we developed the AlzPathway, a prototype of a comprehensive map of AD-related signaling pathways, from information obtained through studies in the public domain. The Al...
Kitano, Hiroaki. A robustness-based approach to systems-oriented drug design. Nature reviews. Drug discovery, vol.6, no.3, 202-210.
Ballard, C., Gauthier, S., Corbett, A., Brayne, C., Aarsland, D., Jones, E.. Alzheimer's disease. The Lancet, vol.377, no.9770, 1019-1031.
Mizuno, Satoshi, Iijima, Risa, Ogishima, Soichi, Kikuchi, Masataka, Matsuoka, Yukiko, Ghosh, Samik, Miyamoto, Tadashi, Miyashita, Akinori, Kuwano, Ryozo, Tanaka, Hiroshi. AlzPathway: a comprehensive map of signaling pathways of Alzheimer’s disease. BMC systems biology, vol.6, 52-52.
Funahashi, Akira, Matsuoka, Yukiko, Jouraku, Akiya, Morohashi, Mineo, Kikuchi, Norihiro, Kitano, Hiroaki. CellDesigner 3.5: A Versatile Modeling Tool for Biochemical Networks. Proceedings of the IEEE, vol.96, no.8, 1254-1265.
Matsuoka, Yukiko, Ghosh, Samik, Kikuchi, Norihiro, Kitano, Hiroaki. Payao: a community platform for SBML pathway model curation. Bioinformatics, vol.26, no.10, 1381-1383.
*원문 PDF 파일 및 링크정보가 존재하지 않을 경우 KISTI DDS 시스템에서 제공하는 원문복사서비스를 사용할 수 있습니다.
※ AI-Helper는 부적절한 답변을 할 수 있습니다.